Law of 1955 regulating the introduction, manufacture, distribution and sale of pharmaceutical and biological products
- The law covers introduction, manufacture, distribution and sale of pharmaceutical and biological products.
- It binds laboratory representatives and depositary agents as well as pharmacists.
- It rests on the Geneva narcotics conventions of 1925 and 1931 and the Final Act of 19 November 1948, with schedules A, B and C.
- It is the statute the 2014 draft law on medicines, also held here, would have replaced.
The law catalogued by FAOLEX as 1955/85, signed by President Paul E. Magloire.
The preamble cites the law of 16 July 1923 on narcotics, the decree-law of 10 July 1940 regulating the practice of medicine, pharmacy and dentistry, the decree-law of 22 November 1945 setting out the public health service's duties, and the law of 5 February 1948 on the control of medicines and pharmaceutical products. It records the Geneva conventions of 19 February 1925 and 13 July 1931 and the Final Act signed at Geneva on 19 November 1948, with schedules A, B and C of narcotics, stupefacients and poisonous substances annexed to those conventions, and states that the introduction, manufacture, distribution and sale of pharmaceutical and biological products must be effectively regulated, by laboratory representatives and depositary agents as much as by pharmacists.
This is the statute the 2014 draft law on medicines held in this corpus would have replaced, and the two read together show what was proposed to change after sixty years. Import and distribution rules for medicines bear directly on drug availability and price, and on the size of the parallel market.
How to cite
Legislative Body of Haiti, Law of 1955 regulating the introduction, manufacture, distribution and sale of pharmaceutical and biological products, https://www.fao.org/faolex/country-profiles/general-profile/en/?iso3=HTI
- Rights holder
- Government of Haiti